Ensign Peak Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-167,325
| Closed | -$17M | – | 1719 |
|
|
2025
Q4 | $17M | Sell |
167,325
-1,154,563
| -87% | -$92.7M | 0.03% | 312 |
|
|
2025
Q3 | $72.3M | Sell |
1,321,888
-65,909
| -5% | -$3.29M | 0.12% | 150 |
|
|
2025
Q2 | $73.7M | Buy |
1,387,797
+168,345
| +14% | +$8.55M | 0.13% | 150 |
|
|
2025
Q1 | $52.8M | Sell |
1,219,452
-69,424
| -5% | -$3.52M | 0.1% | 182 |
|
|
2024
Q4 | $72.4M | Buy |
1,288,876
+87,401
| +7% | +$5.44M | 0.13% | 146 |
|
|
2024
Q3 | $81.8M | Sell |
1,201,475
-613,662
| -34% | -$34.6M | 0.14% | 127 |
|
|
2024
Q2 | $76.7M | Sell |
1,815,137
-607
| -0% | -$33.4K | 0.14% | 129 |
|
|
2024
Q1 | $125M | Buy |
1,815,744
+290,841
| +19% | +$18.4M | 0.23% | 92 |
|
|
2023
Q4 | $113M | Sell |
1,524,903
-498,679
| -25% | -$32.7M | 0.22% | 96 |
|
|
2023
Q3 | $138M | Sell |
2,023,582
-524,645
| -21% | -$44.5M | 0.29% | 75 |
|
|
2023
Q2 | $239M | Sell |
2,548,227
-308,179
| -11% | -$24M | 0.49% | 51 |
|
|
2023
Q1 | $194M | Buy |
2,856,406
+254,519
| +10% | +$16.4M | 0.42% | 57 |
|
|
2022
Q4 | $129M | Buy |
2,601,887
+988,811
| +61% | +$40.4M | 0.29% | 87 |
|
|
2022
Q3 | $52.4M | Sell |
1,613,076
-530,300
| -25% | -$21.9M | 0.13% | 150 |
|
|
2022
Q2 | $84.4M | Sell |
2,143,376
-98,672
| -4% | -$5.28M | 0.2% | 109 |
|
|
2022
Q1 | $157M | Sell |
2,242,048
-146,764
| -6% | -$10.7M | 0.32% | 73 |
|
|
2021
Q4 | $186M | Buy |
2,388,812
+406,554
| +21% | +$35.9M | 0.36% | 70 |
|
|
2021
Q3 | $189M | Buy |
1,982,258
+119,426
| +6% | +$12.6M | 0.39% | 67 |
|
|
2021
Q2 | $232M | Buy |
1,862,832
+103,177
| +6% | +$12.3M | 0.47% | 53 |
|
|
2021
Q1 | $232M | Buy |
1,759,655
+26,468
| +2% | +$3.62M | 0.5% | 49 |
|
|
2020
Q4 | $230M | Sell |
1,733,187
-341,750
| -16% | -$41.3M | 0.52% | 43 |
|
|
2020
Q3 | $212M | Sell |
2,074,937
-201,707
| -9% | -$17.4M | 0.53% | 41 |
|
|
2020
Q2 | $198M | Sell |
2,276,644
-771,335
| -25% | -$61.6M | 0.54% | 44 |
|
|
2020
Q1 | $177M | Buy |
3,047,979
+800,317
| +36% | +$65M | 0.59% | 44 |
|
|
2019
Q4 | $208M | Buy |
+2,247,662
| New | +$198M | 0.55% | 46 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Ensign Peak Advisors's EXAS Position: Q1 2026 in Review
Ensign Peak Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 167,325 shares — an estimated $17M sold.
Ensign Peak Advisors first reported a position in EXAS in Q4 2019 and held it in 25 quarters. The position peaked at $239M in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Ensign Peak Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Ensign Peak Advisors sold 167,325 Exact Sciences shares in Q1 2026, an estimated $17M.
- Ensign Peak Advisors first reported a position in Exact Sciences in Q4 2019 and held it in 25 quarters.
- Ensign Peak Advisors's Exact Sciences position peaked at $239M in Q2 2023.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.